GlassScriptPhysician profile
Edward A Cline
NPI 1306849971
$2,836.59
in general payments reported to CMS, 2019-2025
17 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,574 · 2021: $151 · 2022: $238 · 2023: $208 · 2024: $326 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835 · Education: $39.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.50 |
| Education | $39.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $972.00 | 2019 | |
| Stryker Corporation | $751.27 | 2021-2024 | Prostep Mica, Citrefix, Viaflow |
| Trilliant Surgical LLC. | $412.21 | 2019 | |
| Inari Medical, INC. | $137.68 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Wright Medical Technology, INC. | $116.83 | 2019 | |
| Organogenesis INC. | $105.63 | 2019-2022 | |
| Integra Lifesciences Corporation | $59.95 | 2024-2025 | Integra, Tcc-Ez, Integra Dermal Regeneration Template |
| Arteriocyte Medical Systems, INC. | $58.72 | 2025 | Magellan |
| Neurocrine Biosciences, INC. | $50.15 | 2025 | |
| Smith+Nephew, INC. | $35.35 | 2024-2025 | Grafix Pl, Oasis, Stravix |
| Paragon 28, INC. | $35.23 | 2019-2023 | Monster |
| Vertex Pharmaceuticals Incorporated | $20.76 | 2025 | |
| Solventum Corporation | $19.15 | 2025 | Activ.A.C. |
| Bsn Medical INC | $16.93 | 2025 | |
| Acacia Pharma INC | $15.72 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $15.33 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.68 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.